These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11872327)

  • 1. Successful treatment of reboxetine-induced urinary hesitancy with tamsulosin.
    Kasper S; Wolf R
    Eur Neuropsychopharmacol; 2002 Apr; 12(2):119-22. PubMed ID: 11872327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamsulosin as an effective treatment for reboxetine-associated urinary hesitancy.
    Demyttenaere K; Huygens R; Van Buggenhout R
    Int Clin Psychopharmacol; 2001 Nov; 16(6):353-5. PubMed ID: 11712624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing reboxetine-associated urinary hesitancy in a patient with major depressive disorder: a case study.
    Kasper S
    Psychopharmacology (Berl); 2002 Feb; 159(4):445-6. PubMed ID: 11823898
    [No Abstract]   [Full Text] [Related]  

  • 4. Painful ejaculation and urinary hesitancy in association with antidepressant therapy: relief with tamsulosin.
    Demyttenaere K; Huygens R
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):337-41. PubMed ID: 12126873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxazosin for reboxetine-induced urinary hesitancy.
    Szabadi E
    Br J Psychiatry; 1998 Nov; 173():441-2. PubMed ID: 9926068
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tamsulosin in the treatment of benign prostatic hyperplasia patients with acute urinary retention].
    Hua LX; Wu HF; Sui YG; Chen SG; Xu ZQ; Zhang W; Qian LX
    Zhonghua Nan Ke Xue; 2003 Oct; 9(7):510-1. PubMed ID: 14628599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary retention with reboxetine-fluoxetine combination in a young man.
    Benazzi F
    Can J Psychiatry; 2000 Dec; 45(10):936. PubMed ID: 11190365
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of TAK-802, a novel acetylcholinesterase inhibitor, and tamsulosin, an alpha1-adrenoceptor antagonist, and their synergistic effects on the urodynamic characteristics in a guinea-pig model of functional bladder outlet obstruction.
    Nagabukuro H; Hashimoto T; Iwata M; Doi T
    BJU Int; 2005 May; 95(7):1071-6. PubMed ID: 15839935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.
    Lucas MG; Stephenson TP; Nargund V
    BJU Int; 2005 Feb; 95(3):354-7. PubMed ID: 15679793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of life.
    Djavan B
    Urology; 2003 Sep; 62(3 Suppl 1):6-14. PubMed ID: 12957195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamsulosin for benign prostatic hyperplasia.
    Wilt TJ; Mac Donald R; Rutks I
    Cochrane Database Syst Rev; 2003; (1):CD002081. PubMed ID: 12535426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
    Elshaikh MA; Ulchaker JC; Reddy CA; Angermeier KW; Klein EA; Chehade N; Altman A; Ciezki JP
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):164-9. PubMed ID: 15850917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of antidepressant-induced urinary hesitancy: a focus on levomilnacipran ER including two case presentations(5633).
    Asnis GM; Caneva E; Henderson MA
    Expert Opin Drug Saf; 2016 May; 15(5):717-25. PubMed ID: 26967743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
    Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
    Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial choices and final outcomes in lower urinary tract symptoms.
    Speakman MJ
    Eur Urol; 2001; 40 Suppl 4():21-30. PubMed ID: 11786676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tamsulosin on systemic blood pressure and nonneurogenic dysfunctional voiding in children.
    Vanderbrink BA; Gitlin J; Toro S; Palmer LS
    J Urol; 2009 Feb; 181(2):817-22; discussion 822. PubMed ID: 19110267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reboxetine: a selective norepinephrine reuptake inhibitor for the treatment of depression.
    Scates AC; Doraiswamy PM
    Ann Pharmacother; 2000 Nov; 34(11):1302-12. PubMed ID: 11098346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size.
    Roehrborn CG; Kaplan SA; Jones JS; Wang JT; Bavendam T; Guan Z
    Eur Urol; 2009 Feb; 55(2):472-9. PubMed ID: 18583022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.